C-reactive Protein Testing Market Projected to Exhibit Growth at 2.9% CAGR by 2031- TMR Study

The global C-reactive protein (CRP) testing market witnessed a substantial valuation of US$ 3.1 billion in 2022, with a projected CAGR of 2.9% from 2023 to 2031. By the end of 2031, the market is expected to soar past US$ 4.0 billion, driven by the rising prevalence of chronic diseases and the surge in demand for CRP testing in diagnosis and personalized medicine development.

Technological Advancements and Market Opportunities

Advancements in technology, particularly the development of high-sensitivity CRP assays and point-of-care CRP testing devices, are poised to open lucrative opportunities for market players. Companies are strategically focusing on standardized and accurate CRP tests to gain a competitive edge and expand their market share.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1899&utm_source=OpenPR_Ganesh&utm_medium=OpenPR

Challenges: Lack of Standardization in CRP Testing

While the market is on a growth trajectory, the lack of standardization in CRP testing poses a challenge. This lack of uniformity in testing procedures may lead to variability in results, potentially affecting the accuracy of diagnoses. Addressing this concern is crucial for the sustained growth of the global C-reactive protein testing market.

C-reactive Protein Testing: A Diagnostic Powerhouse

C-reactive protein testing involves measuring the level of CRP, a liver-produced protein in response to inflammation, in a patient's blood. The diagnostic tool plays a crucial role in detecting and managing conditions such as infections, autoimmune diseases, and cardiovascular diseases. It is particularly valuable in identifying inflammation in the body, where elevated CRP levels serve as a key marker.

Driving Forces: Rise in Prevalence of Inflammatory Diseases

The market is set to benefit from the escalating prevalence of inflammatory diseases. CRP, an acute-phase protein linked to inflammation, becomes elevated in response to conditions such as cardiovascular diseases, rheumatoid arthritis, and inflammatory bowel disease. The increase in these diseases is expected to drive the demand for CRP testing.

Point-of-Care Testing (POCT): A Game-Changer

The adoption of point-of-care testing (POCT) for CRP is on the rise, offering rapid and convenient testing in primary care settings, emergency departments, and other point-of-care locations. This trend is expected to propel market growth, with POCT being seen as a cost-effective alternative that provides real-time results, aiding in immediate diagnosis and treatment.

High Adoption of Standard CRP Tests

The standard C-reactive protein test segment, the most commonly used for measuring CRP levels, held the largest market share in 2022. This test, known for its wide availability, low cost, and accurate results, is typically performed by drawing blood from a vein in the arm and is widely utilized in clinical practice.

Immunoturbidimetry Dominates in Assay Techniques

In terms of assay techniques, immunoturbidimetry led the market in 2022. This highly sensitive and specific immunoassay method measures CRP levels using the formation of complexes between CRP and specific antibodies, causing increased turbidity or opacity in the sample. Widely adopted in clinical laboratories, immunoturbidimetry is contributing significantly to CRP testing.

Indications Driving Market Growth

In 2022, the inflammatory diseases segment accounted for a substantial market share, with CRP testing being a valuable tool in diagnosing and monitoring conditions such as rheumatoid arthritis, lupus, and inflammatory bowel disease. The rise in the prevalence and incidence of inflammatory diseases is expected to drive this segment.

End-User Trends: Independent Diagnostic Laboratories Take the Lead

Independent diagnostic laboratories emerged as the dominant end-user segment in 2022, projected to witness rapid growth. The trend of home care diagnostics and testing is a key driver, with independent diagnostic laboratories offering a wide range of services, including direct-to-home testing and digital testing reports.

Regional Landscape: North America Leads, Asia Pacific Grows

North America took the forefront in 2022, driven by the increasing popularity of point-of-care testing, technological advancements, and a rising prevalence of chronic diseases. Meanwhile, the Asia Pacific region is anticipated to experience significant growth, fueled by the increasing prevalence of inflammatory diseases, the demand for early diagnosis, and the availability of advanced CRP testing technologies.

Key Players and Market Strategies

Major players in the global CRP testing market, such as Agilent Technologies, Laboratory Corporation of America Holdings, Thermo Fisher Scientific, and Abbott Laboratories, are adopting strategies like expanding product portfolios and engaging in mergers and acquisitions to enhance market presence.

Key Developments in the Market

In 2021, Randox Laboratories collaborated with Qnostics to develop a new quality control material for CRP testing. Beckman Coulter Life Sciences announced a collaboration with Thermo Fisher Scientific in 2020 to develop and market a new high-sensitivity CRP assay. Abbott launched the Afinion 2 analyzer in May 2018, the latest generation of the Afinion test system, featuring tests for HbA1c, ACR, C-reactive protein (CRP), and the Lipid Panel.

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 | 𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐚𝐭 - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1899&utm_source=OpenPR_Ganesh&utm_medium=OpenPR

the global C-reactive protein testing market is poised for substantial growth, driven by the convergence of technological advancements, rising disease prevalence, and strategic initiatives by key market players. Addressing standardization challenges will be crucial for sustaining this growth.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.